Alnylam (ALNY): Can the RNAi Franchise Get it an Entry into the S&P 500 Index?

insidermonkey.com · 2026-10-20

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) is a biotechnology company built on RNA interference, a technique that switches off the genes behind certain diseases.

Read the full story at insidermonkey.com →